Stock News

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
20 Fastest Growing Health Tech Companies in the World
10 Best Performing Biotech ETFs in 2024
The Dividend Goldmine: 3 Shining Stocks With Growing Payouts
Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
3 Stocks to Buy Low Today With High Hopes for Tomorrow
Is Amgen Stock a Buy?

As seen on...